Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Paul Stockman, MD PHD
AstraZeneca
Study Director - Yung-Jue Bang, MD, PHD
Seoul National University Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
61 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Brussels (Anderlecht), Belgium
- Research Site
Brussels (Woluwé-St-Lambert), Belgium
- Research Site
Leuven, Belgium
- Research Site
Liège, Belgium
- Research Site
Plovdiv, Bulgaria
- Research Site
Sofia, Bulgaria
- Research Site
Vratsa, Bulgaria
- Research Site
Fredericton, New Brunswick, Canada
- Research Site
Toronto, Ontario, Canada
- Research Site
Brno, Czechia
- Research Site
Olomouc, Czechia
- Research Site
Prague, Czechia
- Research Site
Saint-Cloud, France
- Research Site
Villejuif, France
- Research Site
Hamburg, Germany
- Research Site
Mainz, Germany
- Research Site
Budapest, Hungary
- Research Site
Debrecen, Hungary
- Research Site
Nyíregyháza, Hungary
- Research Site
Bangalore, India
- Research Site
Chennai, India
- Research Site
Hyderabad, India
- Research Site
Nagpur, India
- Research Site
Pune, India
- Research Site
Vellore, India
- Research Site
Ancona, Italy
- Research Site
Milan, Italy
- Research Site
Pisa, Italy
- Research Site
Roma, Italy
- Research Site
Chiba, Japan
- Research Site
Chūōku, Japan
- Research Site
Kōtoku, Japan
- Research Site
Nagoya, Japan
- Research Site
Sapporo, Japan
- Research Site
Takatsuki-shi, Japan
- Research Site
Brasov, Romania
- Research Site
Cluj-Napoca, Romania
- Research Site
Anyang-si, South Korea
- Research Site
Daegu, South Korea
- Research Site
Hwasun-gun, South Korea
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2011
- Primary completion
- 31 Aug 2013
- Completion
- 28 Feb 2015
- Last update posted
- 7 Mar 2017
- Registered enrollment
- 960
- Registry id
- NCT01457846
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.